Earnings

Ardent Health Raises FY2026 GAAP EPS Guidance from $0.78-$1.15 to $0.93-$1.18 vs $0.95 Est; Affirms FY2026 Sales Guidance of $6.400B-$6.700B vs $6.463B Est

Nov 4, 2026 · 04:58 PM ET· updated 1h ago

Ardent Health (NYSE:ARDT) raises FY2026 GAAP EPS guidance from $0.78-$1.15 to $0.93-$1.18 vs $0.95 analyst estimate. Affirms FY2026 sales outlook from $6.400 billion-$6.700 billion to $6.400 billion-$6.700 billion vs

Why It Matters

Ardent Health raised its profit forecast for next year, which is good news. The company kept its sales forecast the same, showing they feel steady about growth.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

ARDT14.00

+2.29 (+19.56%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.